Journal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 18, Issue 12, Pages 3616-3621Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2008.04.066
Keywords
hepatitis C virus (HCV); NS5B polymerase; small molecule; non-nucleoside NS5B inhibitor; structure-based design; pyrrolo[1,2-b]pyridazin-2-one
Categories
Ask authors/readers for more resources
Pyrrolo[1,2-b]pyridazin-2-one analogs were discovered as a novel class of inhibitors of genotype 1 HCV NS5B polymerase. Structure-based design led to the discovery of compound 3k, which displayed potent inhibitory activities in biochemical and replicon assays (IC50 (1b) < 10 nM; EC50 (1b) = 12 nM) as well as good stability towards human liver microsomes (HLM t(1/2) > 60 min). (C) 2008 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available